Dr. Kunchok is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- University of Sydney Faculty of MedicineClass of 2010
Certifications & Licensure
- OH State Medical License 2020 - 2026
- MN State Medical License 2018 - 2020
Publications & Presentations
PubMed
- 86 citationsAssociation Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.Amy Kunchok, Allen J. Aksamit, John M. Davis, Orhun H. Kantarci, B. Mark Keegan
JAMA Neurology. 2020-08-01 - 117 citationsSteroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.John J. Chen, Eoin P. Flanagan, M. Tariq Bhatti, Jiraporn Jitprapaikulsan, Divyanshu Dubey
Neurology. 2020-07-14 - 77 citationsComparison of MRI lesion evolution in different central nervous system demyelinating disordersElia Sechi, Karl N. Krecke, Steven A. Messina, Marina Buciuc, Sean J. Pittock
Neurology. 2021-07-14
Journal Articles
- Opsoclonus in Anti-Ma2 Brain-Stem EncephalitisAmy Kunchok, Andrew Mckeon, The New England Journal of Medicine
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAmy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsAmy Kunchok, Allen J Aksamit, Sean J Pittock, Brian G Weinshenker, Andrew Mckeon, JAMA Neurology
Authored Content
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsMay 2020
Press Mentions
- Mark Your Calendar for TSF's Cleveland Patient DayMay 24th, 2024
- NMOSD: True AQP4 Seroconversion Is RareNovember 4th, 2022
- TNF Inhibitors Linked to Inflammatory CNS EventsAugust 25th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: